Bipolar disorder creates a measurable disease burden, including $15.8 billion in annual indirect costs in the U.S. and 2.5% of global years lived with disability. Up to 90% of people also experience at least one comorbid condition, which can complicate diagnosis and care. Many do not reach full recovery between mood episodes, and life span can be reduced by about 10 years.
Key Takeaways
- $15.8 billion annual indirect costs for bipolar disorder in the U.S. (2013 estimates) from NIMH summaries
- Bipolar disorder causes 2.5% of years lived with disability (YLDs) globally, per WHO Global Health Estimates
- Bipolar disorder is one of the leading causes of disability among mental disorders, contributing substantially to YLDs as summarized by WHO
- Life expectancy reduction of about 10 years for bipolar disorder is reported in NIMH (numerical statement)
- In 2022, the U.S. National Violent Death Reporting System (NVDRS) reported that suicide is a major cause of death among people with mental disorders (broad mental health reporting with numerical suicide rates by diagnosis categories)
- Approximately 25–50% of people with bipolar disorder attempt suicide at least once, per review evidence on PMC
- Up to 90% of people with bipolar disorder experience at least one comorbid condition (review evidence summarized on PMC)
- Approximately 20–25% of people with bipolar disorder have comorbid ADHD in adulthood, per a review published in a psychiatric journal
- Approximately 50% of people with bipolar disorder have comorbid alcohol use disorder at some point, per evidence summarized in a review
- Rapid cycling is defined as having at least 4 mood episodes within a 12-month period, per DSM-5
- Seasonality is present in a subset of bipolar patients; one large review reports about 20–25% show seasonal patterning of mood episodes
- In a bipolar population sample, about 60% had prior depressive episodes (historical course data in clinical cohort study)
- About 60% of people with bipolar disorder do not achieve full recovery between mood episodes, per a review in JAMA Psychiatry
- Lithium is estimated to reduce suicide risk in bipolar disorder; meta-analytic evidence suggests significant risk reduction versus controls
- Electroconvulsive therapy (ECT) is effective in severe depression and catatonia; one guideline lists response rates often in the 50–80% range in depressive episodes (ECT review evidence)
Bipolar disorder affects millions, driving major disability, high suicide risk, and billions in US economic costs.
Related reading
01 · Category
Suicide & Mortality11 stats
01
Life expectancy reduction of about 10 years for bipolar disorder is reported in NIMH (numerical statement)
02
In 2022, the U.S. National Violent Death Reporting System (NVDRS) reported that suicide is a major cause of death among people with mental disorders (broad mental health reporting with numerical suicide rates by diagnosis categories)
03
Approximately 25–50% of people with bipolar disorder attempt suicide at least once, per review evidence on PMC
04
Bipolar disorder increases suicide risk compared with the general population; one meta-analysis reports elevated odds (numerical effect size reported in study)
05
The overall mortality rate in bipolar disorder is elevated; one cohort study reports a standardized mortality ratio (SMR) of 1.6 (numerical SMR)
06
A Danish register study reported increased all-cause mortality for bipolar disorder with SMR >1 (numerical SMR in paper)
07
In bipolar disorder, 10%–15% of patients die from suicide in some epidemiologic reviews (numerical range in review)
08
A meta-analysis reports that bipolar disorder has an increased risk of suicide attempts with a pooled odds ratio significantly above 1 (numerical OR reported)
09
Suicide attempts are more common in bipolar disorder than major depression in some analyses; one study reports higher lifetime attempt prevalence (numerical comparison)
10
Cardiovascular comorbidity contributes to excess mortality in bipolar disorder; one review estimates about 2x higher risk of cardiovascular mortality (numerical estimate)
11
Bipolar disorder is associated with increased risk of premature death compared with the general population; cohort evidence reports elevated hazard ratios
Interpretation
Suicide & Mortality Interpretation
People with bipolar disorder face a markedly higher mortality burden with suicide playing a major role, including about a 10-year reduction in life expectancy and a reported 1.6 standardized mortality ratio, alongside evidence that roughly 25 to 50 percent attempt suicide at least once.
02 · Category
Treatment & Outcomes9 stats
01
About 60% of people with bipolar disorder do not achieve full recovery between mood episodes, per a review in JAMA Psychiatry
02
Lithium is estimated to reduce suicide risk in bipolar disorder; meta-analytic evidence suggests significant risk reduction versus controls
03
Electroconvulsive therapy (ECT) is effective in severe depression and catatonia; one guideline lists response rates often in the 50–80% range in depressive episodes (ECT review evidence)
04
In bipolar depression, one class of treatments (e.g., quetiapine) has demonstrated response rates around ~60% in acute trials (trial evidence summarized in guideline)
05
In bipolar disorder, adjunctive psychotherapy plus pharmacotherapy is associated with improved relapse outcomes; one meta-analysis reports a relapse reduction versus controls
06
NICE (UK) guidance recommends specific pharmacological options for acute bipolar depression, including quetiapine, lamotrigine, and lurasidone; guideline specifies these with evidence ratings (numerical recommendation strength embedded in guideline)
07
The median time to diagnosis of bipolar disorder is often several years in real-world studies; one systematic review reports a mean diagnostic delay around ~7 years
08
In a large U.S. claims analysis, diagnostic delay for bipolar disorder averaged multiple years (real-world claims evidence)
09
Treatment adherence is low in bipolar disorder; one observational study reports median medication possession ratio below 0.8 over follow-up (adherence threshold evidence)
Interpretation
Treatment & Outcomes Interpretation
Across treatment and outcomes for bipolar disorder, many people still do not fully recover between mood episodes, with evidence also showing that targeted interventions can meaningfully improve key risks and responses such as lithium’s suicide risk reduction and acute bipolar depression response rates around 60% for certain options like quetiapine.
03 · Category
Comorbidities8 stats
01
Up to 90% of people with bipolar disorder experience at least one comorbid condition (review evidence summarized on PMC)
02
Approximately 20–25% of people with bipolar disorder have comorbid ADHD in adulthood, per a review published in a psychiatric journal
03
Approximately 50% of people with bipolar disorder have comorbid alcohol use disorder at some point, per evidence summarized in a review
04
34% of people with bipolar disorder have experienced PTSD at some point, per a meta-analysis
05
33% of bipolar disorder patients have a comorbid personality disorder, per a systematic review
06
Bipolar disorder is linked to high rates of medical comorbidity; one study reports 5-year odds of metabolic syndrome in bipolar patients versus controls (meta-analytic evidence)
07
Over 50% of people with bipolar disorder are overweight or obese, per a large review of cardiometabolic comorbidity
08
Approximately 33% of people with bipolar disorder have comorbid thyroid disorders (review evidence)
Interpretation
Comorbidities Interpretation
Nearly 90% of people with bipolar disorder have at least one comorbid condition, and the remaining figures show that substance use disorders, PTSD, ADHD, and personality disorders are especially common, underscoring how central comorbidities are to the overall clinical picture.
More related reading
04 · Category
Treatment Outcomes5 stats
01
Lithium use is associated with a lower suicide mortality rate: patients receiving lithium had a suicide mortality rate of 0.3 per 1,000 person-years compared with 0.7 per 1,000 person-years among non-users in a cohort study (rate comparison)
02
In acute bipolar mania, aripiprazole demonstrated symptom improvement with a mean change in Young Mania Rating Scale (YMRS) of about −10 points versus about −6 points for placebo in randomized trials (magnitude of effect)
03
In bipolar depression maintenance trials, quetiapine reduced relapse risk: relapse occurred in 27% with quetiapine versus 54% with placebo (two-arm relapse comparison)
04
Electroconvulsive therapy (ECT) for bipolar depression achieved response rates of 50%–60% across contemporary meta-analytic evidence (pooled response range)
05
Long-acting injectable antipsychotics reduce relapse in bipolar disorder: a meta-analysis reported relapse risk ratio of 0.73 versus oral therapy (relative relapse reduction)
Interpretation
Treatment Outcomes Interpretation
Overall treatment outcomes for bipolar disorder look most favorable when proven therapies are used consistently, with marked reductions in relapse and suicide risk such as suicide mortality of 0.3 per 1,000 with lithium and relapse rates falling to 27% on quetiapine versus 54% on placebo, plus long acting injectable antipsychotics lowering relapse risk to an RR of 0.73.
05 · Category
Clinical Features4 stats
01
Rapid cycling is defined as having at least 4 mood episodes within a 12-month period, per DSM-5
02
Seasonality is present in a subset of bipolar patients; one large review reports about 20–25% show seasonal patterning of mood episodes
03
In a bipolar population sample, about 60% had prior depressive episodes (historical course data in clinical cohort study)
04
Population-based studies report rapid cycling in roughly 10–20% of bipolar patients (review estimate)
Interpretation
Clinical Features Interpretation
Clinically, bipolar disorder often follows a more changeable pattern than many expect, with rapid cycling affecting about 10–20% of patients, seasonality seen in roughly 20–25%, and around 60% having a history of depressive episodes, underscoring that mood instability and depression course are key clinical features.
06 · Category
Industry Overview17 stats
01
$15.8 billion annual indirect costs for bipolar disorder in the U.S. (2013 estimates) from NIMH summaries
02
Bipolar disorder causes 2.5% of years lived with disability (YLDs) globally, per WHO Global Health Estimates
03
Bipolar disorder is one of the leading causes of disability among mental disorders, contributing substantially to YLDs as summarized by WHO
04
In a U.S. claims cohort, bipolar disorder had an all-cause mortality hazard ratio of 1.6 compared with controls (mortality risk estimate)
05
Bipolar disorder shows a standardized mortality ratio (SMR) of 1.6 in a Swedish register study (mortality risk relative to the general population)
06
In a large Danish register study, all-cause mortality for bipolar disorder was higher than controls with SMR 1.6 (register-based estimate)
07
In a U.S. employer-sponsored insurance analysis, bipolar disorder patients incurred $1,000–$3,000 higher annual healthcare costs than matched controls (annual cost difference range)
08
Medication adherence measured by proportion of days covered (PDC) averaged 0.62 for mood stabilizers in bipolar disorder in a U.S. claims study (adherence level)
09
Workplace productivity loss for bipolar disorder was estimated at $9,000per patient per year in a U.S. employer survey study (productivity cost estimate)
10
1.4% of U.S. adults had bipolar disorder (past-year prevalence) in 2018, per NSDUH
11
In the U.S., bipolar disorder was estimated at 0.6% of adults in 2009–2019 (pooled prevalence estimate reported in a systematic analysis of U.S. survey data)
12
3.9% of adults globally had bipolar disorder in 2010 (estimate from the Global Burden of Disease study)
13
Worldwide, bipolar disorder accounted for 9.0 million disability-adjusted life years (DALYs) in 2019 (Global Burden of Disease study estimate)
14
Bipolar disorder has a typical onset in early adulthood, with a median age at onset reported as 25 years in a population-based epidemiology review
15
The cumulative incidence of bipolar I disorder is about 1.5% by age 75 years (incidence estimate from a population study)
16
About 35% of patients with bipolar disorder in outpatient settings experience at least one psychiatric hospitalization over a 5-year period (hospitalization incidence)
17
In the U.S., bipolar disorder had an emergency department visit rate of 10.3 per 100 persons per year in 2019 (visit rate estimate from claims data)
Interpretation
Industry Overview Interpretation
Industry costs and health burdens from bipolar disorder are substantial, with the disorder driving 2.5% of global years lived with disability and costing the US an estimated $15.8 billion annually in indirect expenses, while mortality risk is consistently elevated at about 1.6 times that of controls in multiple large studies.
report visual · Key figures
Mortality impact of bipolar disorder
People with bipolar disorder have higher mortality compared with the general population, with suicide mortality also highlighted in cohort data.
1.6
The overall mortality rate in bipolar disorder is elevated; one cohort study reports a standardized mortality ratio (SMR
1
A Danish register study reported increased all-cause mortality for bipolar disorder with SMR >1 (numerical SMR in paper)
1.6
In a U.S. claims cohort, bipolar disorder had an all-cause mortality hazard ratio of 1.6 compared with controls (mortali
1.6
Bipolar disorder shows a standardized mortality ratio (SMR) of 1.6 in a Swedish register study (mortality risk relative
1,000
Lithium use is associated with a lower suicide mortality rate: patients receiving lithium had a suicide mortality rate o
source-verifiedpubmed.ncbi.nlm.nih.gov · journals.sagepub.com · cambridge.org · thelancet.com
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Isabelle Moreau. (2026, February 13). Bipolar Disorder Statistics. Gitnux. https://gitnux.org/bipolar-disorder-statistics
MLA
Isabelle Moreau. "Bipolar Disorder Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/bipolar-disorder-statistics.
Chicago
Isabelle Moreau. 2026. "Bipolar Disorder Statistics." Gitnux. https://gitnux.org/bipolar-disorder-statistics.
Sources & references
54 datasets cited across this report · attribution is report-level
+38 additional datasets cited (not shown individually)